Pharmacokinetics of drugs in patients with the nephrotic syndrome.
about
Recent advances in drug therapy for epilepsyPopulation pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.Diazepam kinetics in patients with renal insufficiency or hyperthyroidism.Samuel Hyde lecture. Polypharmacy in rheumatoid arthritis--help or hindrance?Impact of glomerular kidney diseases on the clearance of drugs.Drug metabolism under pathological and abnormal physiological states in animals and man.Binding of drugs to tissues.Metabolic disposition of antihyperlipidemic agents in man and laboratory animals.Plasma protein binding of valproic acid in healthy subjects and in patients with renal diseaseConsiderations in the use of drugs in patients with renal failure.Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.Pharmacokinetics of sirolimus (rapamycin) in subjects with mild to moderate hepatic impairment.Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.Protein binding and hepatic extraction of diazepam across the rat liver.Population Pharmacokinetics of Tacrolimus in Children with Nephrotic Syndrome.
P2860
Q24681990-0AD719F7-6C15-4839-B34E-203D4023C75BQ33764995-99AD1F0B-26DB-48A2-913A-C7B2EB206758Q34449546-EA08A7BC-AEC0-4AC3-8F7D-931BB3ADF302Q35779919-30C314C4-6EC2-4CAF-B0A3-0B4240851783Q37974647-972B1252-71D7-4605-83C4-D20745359DA4Q39620103-CF8A632C-534B-4582-A671-C140CF5965B7Q40153521-DB674900-A402-4C1A-A707-B3F7223068DAQ40303400-DE74FF39-C688-4744-9A77-65FCB3036D79Q40897047-BE8C5717-BF62-43E7-B494-503C3A258D32Q44225105-6146F262-A6ED-4219-B30C-F00FE8BB7CD3Q46607005-F4EBB03B-5929-4E64-9C86-CD467A22C492Q46807626-00D0D02F-5610-4089-91FC-3E27529A4CD9Q51847401-BA4229FB-9003-4EEC-AFE1-342CE79CB742Q51853737-2FE9736D-1E62-45F9-9A40-3B2EC0D5DC60Q52594698-FEC2CC55-EB8B-448B-A4F0-23976BF33820
P2860
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
description
1975 nî lūn-bûn
@nan
1975 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
@ast
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
@en
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
@nl
type
label
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
@ast
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
@en
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
@nl
prefLabel
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
@ast
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
@en
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
@nl
P2093
P2860
P356
P1476
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
@en
P2093
Azarnoff DL
Cohlmia JB
Huffman DH
Shoeman DW
P2860
P304
P356
10.1172/JCI108035
P407
P577
1975-06-01T00:00:00Z